Keywords: uk, drug, industryin, review, 1961-1991, addressing, recent
THE UK DRUG INDUSTRYIN REVIEW: 1961-1991
Article | 04 May 1992
Addressing a recent Office of Health Economics-sponsored conference in London, UK, entitled A Perspective on Pharmaceutical Econ-omics: 1942-1992, a meeting ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
